Spencer Center for Vision Research, Byers Eye Institute, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA, USA; Stanford Cardiovascular Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
Spencer Center for Vision Research, Byers Eye Institute, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA, USA.
Prog Retin Eye Res. 2023 Sep;96:101153. doi: 10.1016/j.preteyeres.2022.101153. Epub 2022 Dec 8.
Optogenetics is defined as the combination of genetic and optical methods to induce or inhibit well-defined events in isolated cells, tissues, or animals. While optogenetics within ophthalmology has been primarily applied towards treating inherited retinal disease, there are a myriad of other applications that hold great promise for a variety of eye diseases including cellular regeneration, modulation of mitochondria and metabolism, regulation of intraocular pressure, and pain control. Supported by primary data from the authors' work with in vitro and in vivo applications, we introduce a novel approach to metabolic regulation, Opsins to Restore Cellular ATP (ORCA). We review the fundamental constructs for ophthalmic optogenetics, present current therapeutic approaches and clinical trials, and discuss the future of subcellular and signaling pathway applications for neuroprotection and vision restoration.
光遗传学是指将遗传和光学方法相结合,以在分离的细胞、组织或动物中诱导或抑制明确的事件。虽然眼科中的光遗传学主要应用于治疗遗传性视网膜疾病,但还有许多其他应用在各种眼部疾病中具有广阔的前景,包括细胞再生、线粒体和代谢的调节、眼压的调节和疼痛控制。基于作者在体外和体内应用的初步数据,我们提出了一种新的代谢调节方法,Opsins to Restore Cellular ATP (ORCA)。我们回顾了眼科光遗传学的基本构建,介绍了当前的治疗方法和临床试验,并讨论了亚细胞和信号通路应用在神经保护和视力恢复方面的未来。